BrightSpring Health Services (BTSG) fundamentals: P/E, valuation, undervalued?
BrightSpring Health Services · Health Care · ref. ETF XLV · price $62.65
In short — BrightSpring Health Services trades at 55.4× earnings (P/E), 27.5× forward, with a net margin of 2.5 % and revenue growth of +23 %. Read: Cheap for the growth (P/E 27 for ~197% growth (PEG 0.1)).
Is BrightSpring Health Services stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$62.65+109.4% over range
Oct 14, 25low $29.45 · high $72.91Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 13 analysts
Valuation : Cheap for the growth — P/E 27 for ~197% growth (PEG 0.1)
Valuation
55.4
P/E (price/earnings)
27.5
Forward P/E
0.28
PEG
6.3
Price/book (P/B)
$12.4B
Market cap
1.13
EPS
Profitability & growth
2.5 %
Net margin
+23 %
Revenue growth
+197 %
Earnings growth
$2.4B
Total debt
BrightSpring Health Services income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $0 | $-54M | — |
| 2023 | $8.8B | $-155M | -1.8 % |
| 2024 | $11.3B | $-18M | -0.2 % |
| 2025 | $12.9B | $191M | 1.5 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is BrightSpring Health Services's P/E and is the stock undervalued? What's a good P/E?
BrightSpring Health Services's P/E is 55.4 (forward 27.5). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is BrightSpring Health Services profitable?
BrightSpring Health Services has a net margin of 2.5 % (EPS 1.13). The company is profitable.
Is BTSG stock expensive?
Our read: "Cheap for the growth" — P/E 27 for ~197% growth (PEG 0.1). Cross-check with growth and sector.
💬 A question about BrightSpring Health Services? The JPI assistant answers using our backtest data.
Keep exploring BrightSpring Health Services